Subtitles are available in English and other languages. They are automatically generated using AI, so some errors may occur.
Antithrombotic therapy after TAVI: optimal agents, regimens, and patient selection
TAVI
Pharmacology
Case-based Discussion
Room 243
Watch this session if you want
- To evaluate antithrombotic strategies after TAVI in patients with and without atrial fibrillation, considering thrombotic and bleeding risk
- To analyse the clinical presentation and management of valve thrombosis post-TAVI
- To apply guideline-based decision-making to individualise therapy across diverse post-TAVI scenarios using real patient cases
